Cytosorbents shares
WebApr 12, 2024 · NASDAQ:CTSO Cytosorbents - CTSO Competitors $3.19 -0.09 (-2.74%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $3.05 $3.33 50-Day Range $2.28 $4.17 52-Week Range $1.03 $4.59 Volume 88,732 shs Average Volume 57,011 shs Market Capitalization $139.28 million P/E Ratio N/A Dividend Yield N/A Price Target $5.75 … WebApr 11, 2024 · Shares of Cytosorbents Co. (NASDAQ:CTSO – Get Rating) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.24 and traded as high as $3.33.
Cytosorbents shares
Did you know?
WebNov 4, 2024 · CytoSorbents (CTSO) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.15 per share a year ago. These... WebCytoSorb ® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed …
WebMar 25, 2024 · (RTTNews) - Shares of Cytosorbents Corp. (CTSO) are soaring over 35% in pre-market today, after the company announced that CytoSorb is now specifically recommended in the Italy Brescia Renal COVID ... WebA. The Company and the Investor are parties to a Purchase Agreement dated as of May 5, 2010 (the “Purchase Agreement”), pursuant to which, among other things, the Company has the right to sell to the Investor, at its sole discretion, up to $6,000,000 of the Company’s common stock, par value $0.001 per share (“Common Stock”), upon the terms and …
WebJul 6, 2024 · CytoSorbents Corporation (NASDAQ:CTSO) receives full FDA approval to conduct the STAR-T trial in the U.S. to support regulatory clearance of DrugSorb Antithrombotic Removal (ATR) system for ... WebWhy Cytosorbents Shares Are Popping Off Thursday Henry Khederian - Dec 29, 2024, 1:18PM CytoSorbents Secures US Govt Contract For Customized Filter Freeze-Dried Universal Plasma
WebFeb 15, 2024 · Cytosorbents Corporation Common ... "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and ...
reacting in kindWebJul 22, 2024 · The Company has also granted the underwriters a 30-day option to purchase up to 789,473 additional shares of common stock at the public offering price less the underwriting discount. reacting in communicationsWebJul 6, 2024 · CytoSorbents to Report Fiscal 2024 Operating and Financial Results PR Newswire 25d CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth … how to stop bad breaks in publisherWebShares of CytoSorbents Corp. gained 28.7% in trading on Monday following a Food and Drug Administration announcement late on Friday that grants an to the company's blood … reacting in spanishWebView the latest Cytosorbents Corp. (CTSO) stock price, news, historical charts, analyst ratings and financial information from WSJ. CTSO Cytosorbents Corp. Stock Price & … how to stop bad behavior in adultsWebFeb 21, 2024 · Insiders At Cytosorbents Have Bought Stock Recently. We saw some Cytosorbents insider buying shares in the last three months. CEO & Director Phillip … reacting in rash fashionWebJan 18, 2024 · CytoSorbents Issues Shareholder Letter from CEO and Reports Preliminary Fourth Quarter and Full Year 2024 Revenue The Company expects to report fully-audited financial results for Q4 2024 and... reacting instead of responding